Bernard, R., Hammami, M. B., Arnold, F. W., Mcgrath, B., Patel, A., Wuerth, B., . . . Micic, D. (2022). Clostridioides difficile toxin is infrequently detected in inflammatory bowel disease and does not associate with clinical outcomes. Gut Pathogens, 14(1), 1. https://doi.org/10.1186/s13099-022-00511-2
Chicago Style (17th ed.) CitationBernard, Rachel, Muhammad B. Hammami, Forest W. Arnold, Brian Mcgrath, Alieysa Patel, Brandon Wuerth, Maribeth R. Nicholson, Krishna Rao, and Dejan Micic. "Clostridioides Difficile Toxin Is Infrequently Detected in Inflammatory Bowel Disease and Does Not Associate with Clinical Outcomes." Gut Pathogens 14, no. 1 (2022): 1. https://doi.org/10.1186/s13099-022-00511-2.
MLA (9th ed.) CitationBernard, Rachel, et al. "Clostridioides Difficile Toxin Is Infrequently Detected in Inflammatory Bowel Disease and Does Not Associate with Clinical Outcomes." Gut Pathogens, vol. 14, no. 1, 2022, p. 1, https://doi.org/10.1186/s13099-022-00511-2.